Diabetes and obesity are associated with the risk of cancer. In addition, they increases the risk of recurrence, all-cause mortality, and cancer-associated mortality in some types of cancer. Prevention and glucose-weight control are essential for the public health.

Yesterday it was published this interesting paper, a new oral small molecule inhibitor of lipoprotein (a) formation with impressive results. Important the development of new therapies for reducing residual cardiovascular risk through different mechanisms.

Corre se acaban los espacios. #SmneFID2023 #SMNE2023 #ConstruyamosPuentes endocrinologia.org.mx/foro-internaci…

Sugar-Sweetened beverages (sodas, juices) increases the risk of liver cancer and chronic liver disease mortality (in addition to the risk of diabetes, obesity and cardiovascular disease). We should avoid the consumption of these beverages as much as possible for health reasons.

Even more realistic: 2800 steps a day is associated with a significant reduction in cardiovascular events and all-cause mortality. The more steps per day, the greater the impact as expected. Let's move!

La hipercolesterolemia familiar es una enfermedad silenciosa, cuando da sintomas puede ser por un infarto o muerte subita. Necesitamos hacer con regularidad un perfil de lipidos, si el colesterol total es ≥300 mg/dL (o colesterol LDL ≥190) busquemos atencion medica urgente.

The occurrence of type 2 diabetes in adolescence has increased alarmingly. Mexico occupies one of the first places in the world in this trend. It is our duty to take care of the generations that will be the future. Very relevant article.

Yo dirian que tambien los de 1a generacion"...los farmacos de 2a generacion para tratar obesidad conllevan una gran responsabilidad: entender plenamente su efectos y aprender a maximizar sus beneficios a largo plazo y prevenir o minimizar sus efectos adversos”.

Well-deserved award for tremendous and brilliant contributions to lipids sciences.

Today, the World Diabetes Day, it's important knowing our individual risk for type 2 diabetes. The International Diabetes Federation has released an app, for free, in different languages. Let's do it! It takes a couple of minutes. worlddiabetesday.org/type-2-diabete…

Mañana, miércoles 15 de Noviembre tendremos el primer evento de la Red de Clínicas de Lípidos de México con la participación de los Drs Pablo Corral y Alberico Catapano.

The interest in elevated remnant cholesterol as a direct cause of atherosclerotic cardiovascular disease had a slow start; however, interest has increased enourmously recently among scientists and pharma companies. The term was first used in 2007 in a JAMA paper. Stay tuned!

Los cambios del estilo de vida son fundamentales en el manejo de las enfermedades cardiometabólicas. Una semana de una dieta baja en sal redujo 8 mm Hg la presión arterial sistólica vs dieta alta en sal, una potencia similar a la de fármacos antihipertensivos.

Currently, there is abundant evidence about the important role of inflammation residual risk in cardiovascular events in people on statins, even as important as the residual risk of LDL cholesterol itself. Interesting post-hoc analysis of the CLEAR study.

Apoyo total a la Dra Alethse de la Torre. Sin duda, bajo su liderazgo, el cuidado y manejo de las personas que viven con VIH ha sido extraordinario. #CENSIDA , #INCMNSZ ,

In our last review article, we discuss about how high remnant cholesterol combined with low-grade inflammation may confer a particular high risk for ASCVD. Attention on the dual threat from high remnant cholesterol and low-grade inflammation is necessary. Borge G Nordestgaard

La presente muestra el papel del colesterol remanente elevado y la inflamación de bajo grado, por separado y combinados, en la ASCVD. DOI: 10.1097/MCO.0000000000000999, participación internacional del INCMNSZ Daniel Elías, MD/PhD Borge G Nordestgaard HerlevGentofte Hosp. Mange Tak

In few days, in the 30th Anual Scandinavian Atherosclerosis Conference, I’ll be honoured to present our findings of elevated remnant cholesterol and the risk of ASCVD in individuals with impaired renal function. Borge G Nordestgaard CarlosAguilarSalinas @uiem2017 Dirección de Investigación INCMNSZ @incmnszm

Elevated remnant cholesterol remains a likely cause of ASCVD in diabetes. Remnant cholesterol-lowering therapies should also lower apoB levels to reduce risk of ASCVD: rdcu.be/dVQJg Risk of ASCVD in diabetes in the Copenhagen General Population Study:

Our latest publication in collaboration with Professor Børge Nordestgaard's group from the University of Copenhagen, Denmark. "Impact of remnant cholesterol on cardiovascular risk in diabetes". 👇🏼 link rdcu.be/dVQJg Borge G Nordestgaard